Invitae Secures $40,000,000 Series E Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    458 Brannan Street San Francisco, CA 94107
  • Company Description
    Invitae currently offers testing for a range of hereditary genetic disorders in a variety of clinical disciplines, including oncology, neurology, and pediatric medicine.
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
    Series E
  • Proceeds Purposes
    Invitae will use the financing to accelerate the ongoing development of the company’s clinical genetic tests for hereditary disorders, including oncology, neurology and pediatric medicine.
  • M&A Terms
  • Venture Investor
    Genomic Health
  • Venture Investor
    Thomas, McNerny & Partners
  • Venture Investor
    Redmile Group
  • Venture Investor
    Genesys Capital
  • Venture Investor
    Casdin Capital
  • Venture Investor

Trending on Xconomy